Patents Assigned to Trinity Therapeuties, Inc.
  • Inhibition of immune complex formation
    Patent number: 7584059
    Abstract: Polypeptides and other compounds that can bind specifically to the CH2-CH3 cleft of an immunoglobulin molecule, and methods for using such polypeptides and compounds to inhibit Fc-mediated immune complex formation, are described.
    Type: Grant
    Filed: February 18, 2005
    Date of Patent: September 1, 2009
    Assignee: Trinity Therapeuties, Inc.
    Inventors: Neil M. Bodie, Elliot Altman